A Basic Discussion of Curcumin Quality

September 26, 2017

Turmeric (Curcuma longa) is a yellow spice, part of the ginger family (Zingiberacear) which has been associated with many therapeutic properties. Curcumin compounds in turmeric are thought to be the active agents of many of these properties but the curcuminoids complex found in the rhizome of turmeric contains only 2.5-6% curcumin. Further, the rhizome represents a small fraction of the plant. The three main curcuminoids are: curcumin, bis-demethoxycurcumin and de-methoxycurcumin. They account for 2-6% of the rhizome content (~77% curcumin, ~17% demethoxycurcumin and ~3% bisdemethoxycurcumin). 

Common marketing of Curcumin products in the market today typically refers to a threshold of the 3 main curcuminoids summed, set at a level of 95% by HPLC. “HPLC methods are described by US Pharmacoepia for content measurement of curcuminoids.  One of the original monographs for Curcuminoids for USP was from Sabinsa,” notes Shaheen Majeed, Sabinsa Worldwide President, a Global Curcumin Association Founding member. As with any botanical ingredient or set of ingredients, extraction and concentration becomes increasingly difficult and cost-prohibitive as one approaches 90% and beyond. For that reason, companies exploiting the market opportunity and flouting the law spike the material with a synthetic analogues of curcumin. This reduces cost and will fool the HPLC, masking this illegal activity and causing a false QC positive.

In order to detect this spiking, the current definitive approach is to use isotope ratio analysis (in this case, specifically C-14 measurement) although it could include other isotopes besides carbon such as oxygen and hydrogen (and others). The carbon isotopes are different between synthetic and natural molecules, so those of fossil fuel origin, can be detected quantitatively. Very few labs are equipped to do this testing, so chances are that it is currently not the foundation of many current QC processes, leading high quality curcumin suppliers to suspect that more than a small amount of final product in the marketplace contains synthetic material.

Majeed explains Sabinsa’s position on this subject, “Sabinsa was the company that first alerted the industry to the threat of synthetic adulteration, and continues to raise concerns.  Carbon-14 content measurement has spotted adulteration in curcuminoids that chromatographic techniques and other test methods widely used for identity testing missed. This began with a collaboration between Sabinsa and the University of Georgia to investigate our suspicion that synthetic curcuminoids were in the supply chain in the cut-rate low end of the supply chain. DNA testing can be suitable for verifying the right species of a natural product or herb before it is extracted, but is entirely ineffective when it comes to spotting synthetic adulteration.”

This methodology has much broader applications and potential for this industry as the natural / synthetic debate continues to unfold. According to James Neal-Kababick, Director of Flora Research Laboratories, LLC, “We have used this approach for detecting synthetic caffeine and ascorbic acid.  It can also be used to pedigree a sample (that is, identify that it came from a sole source facility for instance).”

A final point on curcumin quality and testing and the use of synthetic material:

Synthesis of curcumin involves solvents not traditionally used in the natural product extraction process. According to Neal-Kababick, ethylene dichloride is often seen as a residue, in curcumin and other botanicals. If the QC program does not suspect spiking of synthetic curcumin, it might also not be testing for residual solvents. In addition, “these processes have not been tested for human safety, nor has the finished product been proven to be safe when ingested long term, which is how most people use curcumin”, explains Majeed.

And how does this sit with the FDA currently?

While there is ongoing discussion about the most recent NDI guidance, FDA clearly states that a synthetic copy of a botanical cannot be considered as a dietary supplement, hence any presence of a synthetic copy of curcumin would presumably be viewed as adulteration in food, beverages and dietary supplements.

From a science perspective, industry has seen numerous examples of borrowed science, that is, companies citing research on another material as a means of substantiating claims on their own ingredient or brand. According to Majeed, “the amount of research, especially in human clinical trials, on synthetic curcumin is nil. Since synthetic curcumin is not a natural material, FDA is unlikely to authorize any clinical trial.

The Global Curcumin Association (GCA) has been recently launched to provide a consolidated objective voice for the category, to promote and defend quality standards and the strong science that is continuously building for this highly regarded ingredient. Predictably, high growth in a category leads to potential for abuse, exploitation and adulteration. For more information about curcumin, please visit the GCA website.

richard151
Author: richard151

Unlock the Power of Transparency: Schedule a Meeting Now

Ready to Illuminate Your Path?
Partner with Trust Transparency Today.

Get inTouch

Lori Diez

Lori Diez combines compassion and excellence to lead organizations to their next level. A small-town Texas childhood taught her the value of hard work and relationships, which she uses to foster teamwork that brings results that have transformed cultures and programs to their highest potential. Her successful career in pharmaceutical and nutraceutical sales leadership and event hosting has prepared her to deliver results as the COO of TrustTransparency, where she uses her industry knowledge to ensure that the company’s operations run smoothly as they support nutraceutical companies in their mission to help others. Lori’s passion for charity reflects her belief that individuals working together can change the world, no matter how small their contribution to the effort. This year, she looks forward to continuing over a decade of service at the Houston Livestock Show And Rodeo, where she will be the Chairman of the Livestock Committee.

Conference Handouts

Conference Handouts

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 Case Study

CoQ10 Statin Associated Myaglia Meta Study Barry Tan 0618 (1)

Statin Q10 Effect Case Study

Statin Q10 Effect Case Study

Schedule Consultation with Trust Transparency

Glynnda Steinford

Glynnda Steinford, Trust Transparency Consulting’s Director of Customer Relations, brings over four decades of healthcare experience to her vital role in client engagement and relationship building. Her diverse background spans from administering medical groups to impactful stints in pharmaceutical and nutraceutical sales, all underlined by her degree in Healthcare Administration.

At the heart of Glynnda’s work is her talent for nurturing long-term connections, a skill she leverages to enhance client experiences and partnerships within the consultancy. Beyond her professional commitments, she enjoys life’s simple pleasures, whether it’s her love for cats and cooking or her ventures into golf, always prioritizing cherished moments with family and friends. Her personal interests echo the dedication and warmth she extends in her professional network, making her an invaluable asset to the team.

Caiti Dowden

Caiti Dowden stands as a crucial pillar at Trust Transparency Consulting, bringing invaluable insight and expertise to her role as Senior Executive Assistant’ since her start in 2018. With an academic background from Sam Houston University and a career shift from education to the nutraceutical sphere in 2010, Caiti has cultivated a sharp acumen for dissecting industry trends and bolstering strategic decision-making.

Her transition from Data Analyst reflects her growth and deep understanding of the business landscape. Caiti’s commitment goes beyond professional excellence; she thrives on balance, drawing from her rich life outside of work to enhance her organizational contributions. Whether it’s family time, volunteering, or rooting for Houston’s sports teams, she believes in embracing experiences to fuel her professional creativity and insight.

In her current role, Caiti’s dedication to dynamic business analysis and operational support proves her to be an irreplaceable asset to our team, embodying the synergy of personal enrichment and professional success.

Pam Hilpert

Pam Hilpert, Chief of Staff at Trust Transparency Consulting, has been instrumental in the firm since its inception, leveraging her 17 years of accounting experience, including a significant tenure in the nutrition sector. Her collaboration with Scott Steinford spans various successful ventures, emphasizing her integral role in the company’s financial and strategic initiatives.

An alumnus of Sam Houston State University, Pam holds degrees in both Business Administration and Accounting, as well as an MBA, adding academic heft to her practical industry insights. Beyond her professional prowess, Pam is passionate about family, enjoys live music, delves into quilting, and volunteers at her church, reflecting her well-rounded life.

Her multifaceted expertise and longstanding dedication make Pam a cornerstone of Trust Transparency Consulting’s operational strength and team unity.

Scott Steinford

Scott Steinford, a trailblazer in strategic leadership, boasts a certified M&A background, having navigated companies from their genesis to industry prominence. His brainchild, Trust Transparency Consulting, born in 2007, stands as a testament to his dedication to ethical business practices and strategic foresight, offering industry stakeholders invaluable guidance.

Beyond founding and steering companies, Scott has enriched the business landscape with his insightful keynotes and prolific written contributions, emphasizing his commitment to elevating industry standards. His executive tenure shines in roles as CEO or President of for-profits like ZMC-USA and Doctor’s Best, extending to significant contributions in non-profit sectors.

Notably, Scott’s influence is a driving force in the CoQ10 market, where his leadership has significantly bolstered the ingredient’s global presence. His roles in various capacities, including as a New Hope Ambassador, keep the community informed, providing in-depth industry reports and insights.

An active advocate within professional associations and an Editorial Advisor for leading industry publications, Scott’s expertise is both recognized and sought after. With academic roots in Pre-Law and a Master’s in Law, his journey transcends textbooks, embodying real-world business acumen and transformative leadership.

Scott Steinford merges visionary entrepreneurship with principled leadership, creating a legacy of innovation, growth, and unwavering commitment to industry excellence.